FUNCTIONAL AREAS – Page 17

Sample handling deviation during inspection data walkthrough – CAPA package with objective evidence

When a sample handling deviation occurs, it can manifest through various symptoms that alert the Quality Control (QC) team. It's crucial to recognize and document these signals promptly.Click to read…

Method transfer mismatch during inspection data walkthrough – audit trail review steps inspectors expect

Identifying signals of a method transfer mismatch is the first step in addressing potential problems. Symptoms may manifest as:Click to read the full article.

Instrument qualification gap during investigation phase – FDA data integrity risk and corrective actions

Identifying symptoms that signal gaps in instrument qualification is vital for timely and effective intervention. Common indicators include:Click to read the full article.

Instrument qualification gap during investigation phase – improving right-first-time testing metrics

Identifying the initial signs of instrument qualification gaps is crucial. Common symptoms that may indicate an underlying issue include:Click to read the full article.

Method transfer mismatch during inspection data walkthrough – CAPA package with objective evidence

The first step in addressing a method transfer mismatch is recognizing the symptoms. Common signals include:Click to read the full article.

Analyst technique variability during investigation phase – audit trail review steps inspectors expect

Detecting symptoms of analyst technique variability is the first crucial step in any investigation. These symptoms can manifest in various forms, including:Click to read the full article.

CSV not aligned to actual use during continued process verification – documentation pitfalls that trigger 483 observations

Identifying symptoms that suggest CSV is not aligned to actual use is the first step in mitigating potential compliance risks. Common indicators include:Click to read the full article.

Inadequate worst-case justification during change control review – documentation pitfalls that trigger 483 observations

The first step in addressing inadequate worst-case justifications is recognizing the symptoms or signals that indicate a problem may exist within the change control process. These signals often manifest as…

Periodic review overdue during validation lifecycle – documentation pitfalls that trigger 483 observations

Identifying signals that indicate a deviation such as overdue periodic reviews can vary from informal reports to formal deviations logged in quality systems. Below are some observable symptoms:Click to read…

Incomplete impact assessment during tech transfer validation – how to prevent repeat validation failures

Addressing Incomplete Impact Assessments in Tech Transfer Validation to Prevent Future Failures The pharmaceutical industry faces numerous challenges during the technology transfer of manufacturing processes and product formulations. One significant…

Revalidation not triggered after change during tech transfer validation – risk-based validation strategy aligned to FDA/EMA

When a tech transfer is executed, various symptoms may signal that revalidation is required but not performed. Key signals to monitor include:Click to read the full article.

Periodic review overdue during validation lifecycle – risk-based validation strategy aligned to FDA/EMA

Investigating Periodic Review Overdue During the Validation Lifecycle In the realm of pharmaceutical manufacturing and quality assurance, having an overdue periodic review during the validation lifecycle can raise significant concerns…